📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
World Ayahuasca Forum Brings Ancestral Intelligence to Spain
PLUS, an interview with an iconic Grateful Dead artist, ayahuasca and loneliness, and Puerto Rico's executive order. [...] Read More... The post World Ayahuasca Forum Brings Ancestral Intelligence to Spain appeared fi...
Citizen Science x Phenomenology
Journaling, editing, reflecting, integrating – all remain valid when formalising your anecdotal report, to make sense of everything you experienced during your protocol. But, what if the quality of your microdosing e...
The Psychedelic Future We Were Promised
This Week's Sunday Insider: Why the Psychedelic Future Never Arrived.
Weekly Psychedelic Policy Briefing – August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research organization ICON will bring Anthropic's Claude AI tool into clinical trials involving drug developme...
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psychedelics researchers
9 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states shape relationships, grief, death & meaning.
Puerto Rico Makes Moves on Ibogaine, MDMA, and Psilocybin
The island's governor just signed an executive order effectively launching a pilot program to research psychedelic therapy. [...] Read More... The post Puerto Rico Makes Moves on Ibogaine, MDMA, and Psilocybin appeare...
Why Perimenopause Belongs in Psychedelic Research
Perimenopause is one of the least-researched transitions in women's health. Some women are already microdosing San Pedro to get through it. Deva Collective's founder on why that experience deserves to be studied, not ...
Microdosing for Anxiety: What the Evidence Shows, and Where It Doesn’t
Microdosing for anxiety looks encouraging in open-label surveys and far less convincing under placebo control. What facilitators need to know about the evidence, the protocols, the contraindications, and the backfire ...
Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and the Post-Psychedelic Challenges Study
What happens when a psychedelic experience continues causing problems long after the trip ends? Emory researchers Josh Lipson and Roman Palitsky discuss psychedelic harms, HPPD, spiritual crisis, adverse events, and t...
The Toads Didn’t Consent to Being Milked, Sorry
Chasing "enlightenment" at the expense of desert toads is not the flex you think it is. [...] Read More... The post The Toads Didn’t Consent to Being Milked, Sorry appeared first on DoubleBlind Mag.
Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing
For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Eyeshades and headphones. A therapist sitting with a patient for six or eight hours while a single dos...
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High
Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the antidepressant benefits people associate with psychedelics without the trip? On August 5, 2026, the...
Weekly Psychedelic Policy Briefing – August 9, 2026
Jack Gorsline, investigative journalist, covers four federal developments this week. The Department of Veterans Affairs launched a five-site psilocybin trial, and the drug it runs on belongs to a company preparing an ...